OrbiMed Advisors LLC's Form 4 filing
NeuroPace Inc (NPCE) · filed Apr 23, 2024
- Accession no.
- 0000947871-24-000410
- Filed
- Apr 23, 2024, 6:38 PM ET
- Trade date
- Apr 19-23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $913.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Common Stock | SSaleDisposed | −18,253 | $14.02 | −$255,907.06 | 3,483,722 | Indirect | |
| Apr 22, 2024 | Common Stock | SSaleDisposed | −24,609 | $14.05 | −$345,756.45 | 3,459,113 | Indirect | |
| Apr 23, 2024 | Common Stock | SSaleDisposed | −21,791 | $14.29 | −$311,393.39 | 3,437,322 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.